[1] [1] ERDOES G, BASCIANI R M, EBERLE B. Etomidate—a review of robust evidence for its use in various clinical scenarios[J]. Acta Anaesthesiol Scand, 2014, 58(4): 380-389.

[4] [4] SCHWARZKOPF K R, HUETER L, SIMON M, et al. Midazolam pretreatment reduces etomidate-induced myoclonic movements[J]. Anaesth Intensive Care, 2003, 31(1): 18-20.

[7] [7] SEDIGHINEJAD A, NADERI N B, HAGHIGHI M, et al. Comparison of the effects of low-dose midazolam, magnesium sulfate, remifentanil and low-dose etomidate on prevention of etomidate-induced myoclonus in orthopedic surgeries[J]. Anesth Pain Med, 2016, 6(2): e35333.

[8] [8] DEY S, KUMAR M. Comparison of pretreatment with dexmedetomidine with midazolam for prevention of etomidate-induced myoclonus and attenuation of stress response at intubation: a randomized controlled study[J]. J Anaesthesiol Clin Pharmacol, 2018, 34(1): 94-98.

[13] [13] RAUTELA R S, GULABANI M, KUMAR P, et al. Comparative assessment of dexmedetomidine and butorphanol for attenuation of etomidate-induced myoclonus: a double-blind, randomised controlled study[J]. Indian J Anaesth, 2023, 67(9): 815-820.

[14] [14] LV Z, FANG J, ZHU J, et al. Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate[J]. J Anesth, 2014, 28(6): 944-947.

[19] [19] MIZRAK A, KORUK S, BILGI M, et al. Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial[J]. J Surg Res, 2010, 159(1): e11-e16.

[23] [23] LUAN H F, ZHAO Z B, FENG J Y, et al. Prevention of etomidate-induced myoclonus during anesthetic induction by pretreatment with dexmedetomidine[J]. Braz J Med Biol Res, 2015, 48(2): 186-190.

[24] [24] MIAO S, ZOU L, WANG G, et al. Effect of dexmedetomidine on etomidate-induced myoclonus: a randomized, double-blind controlled trial[J]. Drug Des Devel Ther, 2019, 27(13): 1803-1808.

[27] [27] GHODKI P S, SHETYE N N. Pretreatment with dexmedetomidine and magnesium sulphate in prevention of etomidate induced myoclonus—a double blinded randomised controlled trial[J]. Indian J Anaesth, 2021, 65(5): 404-407.

[28] [28] KELSAKA E, KARAKAYAD, SARIHASANB, etal. Remifentanil pretreatment reduces myoclonus after etomidate[J]. J Clin Anesth, 2006, 18(2): 83-86.

[29] [29] HWANG J Y, KIM J H, OH A Y, et al. A comparison of midazolam with remifentanil for the prevention of myoclonic movements following etomidate injection[J]. J Int Med Res, 2008, 36(1): 17-22.

[33] [33] LEE S W, GILL H J, PARK S C, et al. The effect of remifentanil for reducing myoclonus during induction of anesthesia with etomidate[J]. Korean J Anesthesiol, 2009, 57(4): 438-443.

[37] [37] HUETER L, SCHWARZKOPF K, SIMON M, et al. Pretreatment with sufentanil reduces myoclonus after etomidate[J]. Acta Anaesthesiol Scand, 2003, 47(4): 482-484.

[40] [40] WANG W, LV J, WANG Q, et al. Oxycodone for prevention of etomidate-induced myoclonus: a randomized double-blind controlled trial[J]. J Int Med Res, 2018, 46(5): 1839-1845.

[41] [41] ZHANG K D, WANG L Y, ZHANG D X, et al. Comparison of the effectiveness of various drug interventions to prevent etomidate-induced myoclonus: a Bayesian network Meta-analysis[J]. Front Med (Lausanne), 2022, 26(9): 799156.

[44] [44] YILMAZ C M, DEMIREL I, DURAN E, et al. Effect of gabapentin pretreatment on myoclonus after etomidate: a randomized, double-blind, placebo-controlled study[J]. Braz J Anesthesiol, 2016, 66(4): 356-362.

[45] [45] LOACKER S, SAYYAH M, WITTMANN W, et al. Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors[J]. Brain, 2007, 130(4): 1017-1028.

[46] [46] GHARAGOZLOU P, HASHEMI E, DELOREY T M, et al. Pharmacological pro-files of opioid ligands at kappa opioid receptors[J]. BMC Pharmacol, 2006(6): 3.